Medline Inc - Class A risk profile
64 Stretched several inputs deteriorating together
Measured 21 October 2026 from MDLN's filed statements. Recomputed nightly.
64 (Stretched), driven by Concentration at 92, over 6 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 49 | Elevated | Volatile | One-year price volatility — 44.5% |
| Operating pressure | 39 | Normal | Worsening | Costs outgrowing revenue — +0.9 percentage points |
| Cash conversion | 56 | Elevated | Worsening | Cash conversion — 0.00x |
| Leverage and coverage | 41 | Elevated | Easing | Interest cover — 3.41x |
| Competitive position | 72 | Stretched | Stable | Operating-margin gap against peers — -4.1 percentage points |
| Concentration | 92 | Acute | Stable | Geographic concentration — 8,673 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Healthcare companies with a risk reading
Lilly(Eli) & Company 33Johnson & Johnson 39Abbvie Inc 57Unitedhealth Group Inc 43Roche Holding AG 35Merck & Co Inc 35Novartis AG 29Novartis AG 31Astrazeneca plc 33Thermo Fisher Scientific Inc 44AMGEN Inc 47Gilead Sciences Inc 51
Financials, valuation and price history for Medline Inc - Class A